Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Amundi
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Amundi
from 13F filings
Historical chart of Amundi investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Amundi consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Amundi
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $735M | 5.0M | 147.03 |
| 2025-06-30 | $4.2M | 3.2M | 1.31 |
| 2025-03-31 | $3.6M | 3.2M | 1.13 |
| 2024-12-31 | $3.4M | 3.2M | 1.08 |
| 2024-09-30 | $3.7M | 3.2M | 1.16 |
| 2024-03-31 | $2.9M | 3.2M | 0.92 |
| 2023-12-31 | $3.2M | 3.2M | 1.01 |
| 2023-09-30 | $3.5M | 3.9M | 0.90 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1